CLINICAL_TRIALS
research
· 2026-04-08
Clinical Trial Update: MANDARIN (S6371) [Phase 3]
Summary
A Phase 3 clinical trial called MANDARIN (S6371) by Boston Scientific is currently active but not recruiting for inoperable hepatocellular carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Inoperable Hepatocellular Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING